{"id":83995,"date":"2023-03-14T12:04:12","date_gmt":"2023-03-14T11:04:12","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/"},"modified":"2025-10-13T15:25:26","modified_gmt":"2025-10-13T13:25:26","slug":"el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/","title":{"rendered":"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics"},"content":{"rendered":"<p><strong>El <a href=\"https:\/\/www.cdti.es\/\" target=\"_blank\" rel=\"noopener\">CDTI Innovaci\u00f3n<\/a>, a trav\u00e9s del programa Innvierte, y <a href=\"https:\/\/asabys.com\/\" target=\"_blank\" rel=\"noopener\">Asabys Partners<\/a>, a trav\u00e9s del fondo Sabadell Asabys Health Innovation Investments, han conseguido un acuerdo con los socios de <a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/nuage-therapeutics\/\" target=\"_blank\" rel=\"noopener\">Nuage Therapeutics<\/a> para invertir en la startup. La aportaci\u00f3n comprometida por el CDTI es de 450.000 euros. Con esta inyecci\u00f3n de capital, la biotecnol\u00f3gica, con sede en el Parque Cient\u00edfico de Barcelona, quiere avanzar en el desarrollo de su tecnolog\u00eda para acercar su primer producto terap\u00e9utico a pacientes oncol\u00f3gicos.<\/strong><\/p>\n<p><a href=\"https:\/\/nuagetx.com\/\" target=\"_blank\" rel=\"noopener\">Nuage Tx<\/a>\u00a0naci\u00f3 el 2021 como spin-off del Instituto de Investigaci\u00f3n Biom\u00e9dica (<a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/institut-de-recerca-biomedica-irb-barcelona\/\" target=\"_blank\" rel=\"noopener\">IRB Barcelona<\/a>) y la Instituci\u00f3n Catalana de Investigaci\u00f3n y Estudios Avanzados (<a href=\"https:\/\/www.icrea.cat\/es\" target=\"_blank\" rel=\"noopener\">ICREA<\/a>), por iniciativa del Dr. Xavier Salvatella y el Dr. Mateusz Biesaga, del IRB Barcelona; el Dr. Denes Hnisz, de Max Planck Institute for Molecular Genetics en Berl\u00edn; y la Dra. Judit Anido, cient\u00edfica y emprendedora con experiencia en la creaci\u00f3n y desarrollo de empresas biotecnol\u00f3gicas.<\/p>\n<p>La compa\u00f1\u00eda est\u00e1 desarrollando nuevos f\u00e1rmacos dirigidos a dianas terap\u00e9uticas consideradas inabordables hasta hoy por la industria farmac\u00e9utica a causa de su falta de estructura. Estas dianas terap\u00e9uticas son conocidas como Prote\u00ednas Intr\u00ednsecamente Desordenadas (PIDs) y se han relacionado en numerosas ocasiones con enfermedades con necesidades m\u00e9dicas no cubiertas, como el c\u00e1ncer.<\/p>\n<p>El primer programa de Nuage Tx tiene como objetivo desarrollar, mediante su tecnolog\u00eda, un nuevo f\u00e1rmaco potente y selectivo dirigido a pacientes con determinados tipos de c\u00e1ncer de pr\u00f3stata.<\/p>\n<p>\u00bb<strong> M\u00e1s informaci\u00f3n en este<a href=\"http:\/\/perspectivacdti.com\/el-cdti-innovacion-invierte-junto-a-asabys-partners-en-nuage-therapeutics-startup-que-desarrolla-nuevos-farmacos-con-potencial-aplicacion-en-oncologia\/\" target=\"_blank\" rel=\"noopener\"> enlace [+]<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El CDTI Innovaci\u00f3n, a trav\u00e9s del programa Innvierte, y Asabys Partners, a trav\u00e9s del fondo Sabadell Asabys Health Innovation Investments, han conseguido un acuerdo con los socios de Nuage Therapeutics&#8230;<\/p>\n","protected":false},"author":14,"featured_media":83081,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-83995","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El CDTI Innovaci\u00f3n, a trav\u00e9s del programa Innvierte, y Asabys Partners, a trav\u00e9s del fondo Sabadell Asabys Health Innovation Investments, han conseguido un acuerdo con los socios de Nuage Therapeutics...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-14T11:04:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:25:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/03\/coinversion-Nuage-Tx.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics\",\"datePublished\":\"2023-03-14T11:04:12+00:00\",\"dateModified\":\"2025-10-13T13:25:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/coinversion-Nuage-Tx.jpg\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/\",\"name\":\"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/coinversion-Nuage-Tx.jpg\",\"datePublished\":\"2023-03-14T11:04:12+00:00\",\"dateModified\":\"2025-10-13T13:25:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/coinversion-Nuage-Tx.jpg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/coinversion-Nuage-Tx.jpg\",\"width\":900,\"height\":416},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/","og_locale":"es_ES","og_type":"article","og_title":"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics - Parc Cient\u00edfic de Barcelona","og_description":"El CDTI Innovaci\u00f3n, a trav\u00e9s del programa Innvierte, y Asabys Partners, a trav\u00e9s del fondo Sabadell Asabys Health Innovation Investments, han conseguido un acuerdo con los socios de Nuage Therapeutics...","og_url":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2023-03-14T11:04:12+00:00","article_modified_time":"2025-10-13T13:25:26+00:00","og_image":[{"width":900,"height":416,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/03\/coinversion-Nuage-Tx.jpg","type":"image\/jpeg"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics","datePublished":"2023-03-14T11:04:12+00:00","dateModified":"2025-10-13T13:25:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/"},"wordCount":276,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/03\/coinversion-Nuage-Tx.jpg","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/","url":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/","name":"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/03\/coinversion-Nuage-Tx.jpg","datePublished":"2023-03-14T11:04:12+00:00","dateModified":"2025-10-13T13:25:26+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/03\/coinversion-Nuage-Tx.jpg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2023\/03\/coinversion-Nuage-Tx.jpg","width":900,"height":416},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/el-cdti-innovacion-y-asabys-partners-invierten-en-la-startup-nuage-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"El CDTI Innovaci\u00f3n y Asabys Partners invierten en la startup Nuage Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/83995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=83995"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/83995\/revisions"}],"predecessor-version":[{"id":87773,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/83995\/revisions\/87773"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/83081"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=83995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=83995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=83995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}